$5.40
arrow_drop_down3.22%Key Stats | |
---|---|
Open | $5.50 |
Prev. Close | $5.58 |
EPS | -1.50 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 5.24 | 5.59 |
52 Week Range | 1.62 | 7.66 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.50 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?
Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Black Diamond (BDTX) is on the Move, Here's Why the Trend Could be Sustainable
Does Black Diamond (BDTX) Have the Potential to Rally 152.96% as Wall Street Analysts Expect?